What Are Liver Neoplasms?

Liver neoplasms are abnormal tissue growths originating in or metastasizing to the liver, encompassing both benign lesions and malignant tumors. They represent one of the most serious categories of hepatic disease, with hepatocellular carcinoma (HCC) ranking among the most common and lethal malignancies worldwide. In biomedical engineering and medical imaging, liver neoplasms are a primary target for the development of computer-aided detection systems, segmentation algorithms, and interventional guidance technologies.

The classification of liver neoplasms follows the distinction between primary tumors, which arise from the liver's own cell populations, and secondary (metastatic) tumors, which spread from distant sites such as the colon, lung, or breast. Within primary tumors, hepatocellular carcinoma accounts for the majority of cases, with cholangiocarcinoma (arising from bile duct epithelium) representing the second most frequent primary malignancy. Metastatic colorectal carcinoma is the most common secondary liver malignancy in Western populations.

Primary and Secondary Liver Tumors

Hepatocellular carcinoma typically arises in the setting of chronic liver disease, cirrhosis being the most significant predisposing condition. Tumor cells derive from hepatocytes and commonly show hypervascularity on contrast-enhanced CT and MRI, displaying a characteristic arterial enhancement and venous washout pattern called the LI-RADS (Liver Imaging Reporting and Data System) enhancement signature. Intrahepatic cholangiocarcinoma, by contrast, tends toward hypovascularity and peripheral enhancement. Benign hepatic neoplasms include hemangiomas, focal nodular hyperplasia, and hepatic adenomas, each with distinct radiological and pathological signatures that must be differentiated from malignant lesions. A comprehensive framework for imaging-based differentiation is presented in the PMC review on imaging of liver cancer.

Imaging and Computer-Aided Detection

Multidetector CT and gadolinium-enhanced MRI are the primary modalities for detecting and characterizing liver neoplasms, offering submillimeter spatial resolution and the ability to assess lesion hemodynamics through dynamic contrast imaging. Deep learning algorithms trained on large annotated CT databases can segment hepatic tumors and quantify volume with accuracy approaching that of expert radiologists. The Liver Tumor Segmentation Benchmark (LiTS), a publicly available dataset of annotated CT scans, has become a standard evaluation framework for segmentation models. IEEE publications have documented neural network architectures and feature-extraction pipelines for automated liver tumor detection, including IEEE conference research on detection of liver cancer using image processing, which reports convolutional approaches applied to CT images. Positron emission tomography (PET) and hybrid PET/CT imaging extend detection capability by identifying metabolically active deposits below the morphological detection threshold of CT alone.

Interventional and Surgical Technologies

Treatment of liver neoplasms depends on tumor stage, number, size, and hepatic reserve. Surgical resection and liver transplantation remain the mainstays for potentially curative treatment of HCC, and preoperative volumetric planning using CT-derived segmentation is standard practice. Locoregional ablative therapies, including radiofrequency ablation, microwave ablation, and irreversible electroporation, deliver targeted energy to destroy tumors while sparing surrounding parenchyma. Transarterial chemoembolization (TACE) exploits the tumor's arterial supply to deliver chemotherapy and embolic agents selectively. Image-guided robotic systems, real-time ultrasound fusion guidance, and electromagnetic tracking are engineering contributions that increase ablation precision. A PMC review of computerized imaging for liver disease and interventional surgery surveys recent advances across all of these imaging and procedural technology areas.

Applications

Liver neoplasms research and detection technology have applications in a range of clinical and engineering disciplines, including:

• Computer-aided detection and segmentation for radiology workstations
• Surgical planning platforms for hepatic resection margin estimation
• Ablation guidance systems using real-time image fusion
• Predictive models for treatment response assessment in HCC
• Biomarker-based surveillance systems for high-risk patient populations